ALVO OAKTREE ACQUISITION CORP II

Leiðrétting: Viðskipti stjórnenda og tengdra aðila

Leiðrétting: Viðskipti stjórnenda og tengdra aðila

Í viðhengi er tilkynning um viðskipti stjórnenda og tengdra aðila sem lögð var inn til birtingar hjá fjármálaeftirliti Lúxemborgar, Luxembourg Commission de Surveillance du Secteur Financier (CSSF), um kaup Alvogen Lux Holdings S.ár.l. á 210,000 hlutum í Alvotech á genginu 1.277,38 krónur á hlut. Alvogen Lux Holdings er annar stærsti hluthafi Alvotech. Stærstu hluthafar Alvogen Lux Holdings eru fjárfestingasjóðirnir CVC (40%), Aztiq (30%) og Temasek (20%).

(Leiðréttingin varðar fjölda keyptra hluta, sem voru sagðir 201,000 í upprunalegu íslensku útgáfu tilkynningarinnar) 

Viðhengi



EN
13/05/2025

Underlying

ALVOOAKTREE ACQUISITION CORP II

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on OAKTREE ACQUISITION CORP II

 PRESS RELEASE
Free
ALVO OAKTREE ACQUISI...

Alvotech Appoints Linda Jónsdóttir as Chief Financial Officer

Alvotech Appoints Linda Jónsdóttir as Chief Financial Officer REYKJAVIK, ICELAND (July 10, 2025) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the appointment of Linda Jónsdóttir as Chief Financial Officer (CFO). Linda is a highly experienced international executive with a strong background in finance and corporate leadership. She has held senior roles across a range of industries, including banking, food technology, transportation, and healthcare. Linda will be based in Ice...

July 10, 2025 1 EN
 PRESS RELEASE
Free
ALVO OAKTREE ACQUISI...

Alvotech Appoints Linda Jónsdóttir as Chief Financial Officer

Alvotech Appoints Linda Jónsdóttir as Chief Financial Officer REYKJAVIK, Iceland, July 10, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the appointment of Linda Jónsdóttir as Chief Financial Officer (CFO). Linda is a highly experienced international executive with a strong background in finance and corporate leadership. She has held senior roles across a range of industries, including banking, food technology, transportation, and healthcare. Linda w...

July 10, 2025 1 EN
 PRESS RELEASE
Free
ALVO OAKTREE ACQUISI...

Alvotech skipar Lindu Jónsdóttur í stöðu framkvæmdastjóra fjármálasvið...

Alvotech skipar Lindu Jónsdóttur í stöðu framkvæmdastjóra fjármálasviðs REYKJAVÍK (10. JÚLÍ 2025) - Alvotech (NASDAQ: ALVO) hefur skipað Lindu Jónsdóttur í stöðu framkvæmdastjóra fjármálasviðs. Linda er reyndur alþjóðlegur stjórnandi á sviði rekstrar og fjármála. Hún hefur áður gegnt leiðtogastöðum fyrirtækja á sviði iðnaðar, fjármála, flutningastarfsemi og heilbrigðismála. Joel Morales sem verið hefur framkvæmdastjóri fjármálasviðs Alvotech frá árinu 2020 hefur ákveðið að láta af störfum til þess að geta varið meiri tíma með fjölskyldunni og á heimaslóðum í Bandaríkjunum. Hann verður félag...

July 10, 2025 1 EN
 PRESS RELEASE
Free
ALVO OAKTREE ACQUISI...

Alvotech erweitert seine Kapazitäten in den Bereichen Montage und Verp...

Alvotech erweitert seine Kapazitäten in den Bereichen Montage und Verpackung mit der Akquisition von Ivers-Lee in der Schweiz REYKJAVIK, ISLAND UND BURGDORF, SCHWEIZ (9. JULI 2025) — Alvotech (NASDAQ: ALVO), ein globales Biotech-Unternehmen, das sich auf die Entwicklung und Herstellung von Biosimilars für Patienten weltweit spezialisiert hat, gab heute die Erweiterung seiner Kapazitäten für Montage und Verpackung durch die Übernahme der Ivers-Lee Gruppe ("Ivers-Lee") bekannt, einem Familienunternehmen in Burgdorf, Schweiz, das sich auf die Bereitstellung hochwertiger Montage- und Verpackung...

July 9, 2025 1 EN
 PRESS RELEASE
Free
ALVO OAKTREE ACQUISI...

Alvotech Expands its Capacity in Assembly and Packaging with the Acqui...

Alvotech Expands its Capacity in Assembly and Packaging with the Acquisition of Ivers-Lee Group in Switzerland REYKJAVIK, ICELAND AND BURGDORF, SWITZERLAND (JULY 9, 2025) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the expansion of its capacity for assembly and packaging with the acquisition of Ivers-Lee Group (“Ivers-Lee”), a family owned business with headquarters in Burgdorf, Switzerland specializing in providing high-quality assembly and packaging services for the phar...

July 9, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch